# OnCo record tub-030 (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/tub-030/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "tub-030" ;
  schema:name "TUB-030"@en ;
  schema:description "TUB-030 is an experimental antibody-drug conjugate from Tubulis (Gilead), in phase 1 trials for advanced solid tumours, head and neck squamous cell carcinoma and small cell lung cancer and other cancers."@en ;
  schema:url <https://onco.cc/drugs/tub-030/> ;
  schema:dateModified "2026-11-03"^^xsd:date ;
  schema:citation <https://tubulis.com/our-pipeline/>, <https://tubulis.com/our-pipeline/>, <https://tubulis.com/news/gilead-to-acquire-tubulis-adding-potentially-best-in-class-antibody-drug-conjugate-and-next-generation-platform-to-further-strengthen-oncology-pipeline/>, <https://clinicaltrials.gov/search?intr=TUB-030> ;
  onco:status "phase-1" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:modality "Antibody-drug conjugate" ;
  onco:cancers <https://onco.cc/cancers/metastatic-cancer/>, <https://onco.cc/cancers/sclc/>, <https://onco.cc/cancers/nsclc/>, <https://onco.cc/cancers/tnbc/> ;
  onco:companies <https://onco.cc/companies/tubulis/> ;
  onco:trials <https://onco.cc/trials/nct06657222/> .